Safety review of 20-valent pneumococcal conjugate vaccine

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2039卷 / 1期
关键词：
D O I：
10.1007/s40278-024-72446-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 9
相关论文
共 50 条
  • [1] 20-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults
    Shirley, Matt
    DRUGS, 2022, 82 (09) : 989 - 999
  • [2] 20-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults
    Matt Shirley
    Drugs, 2022, 82 : 989 - 999
  • [3] 20-Valent Pneumococcal Conjugate Vaccine: Pediatric First Approval
    Shirley, Matt
    PEDIATRIC DRUGS, 2023, 25 (05) : 613 - 619
  • [4] Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States
    Senders, Shelly
    Klein, Nicola P.
    Lamberth, Erik
    Thompson, Allison
    Drozd, Jelena
    Trammel, James
    Peng, Yahong
    Giardina, Peter C.
    Jansen, Kathrin U.
    Gruber, William C.
    Scott, Daniel A.
    Watson, Wendy
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (10) : 944 - 951
  • [5] The 20-valent pneumococcal conjugate vaccine (PCV20): expected added value
    Janssens, Esther
    Flamaing, Johan
    Vandermeulen, Corinne
    Peetermans, Willy E.
    Desmet, Stefanie
    De Munter, Paul
    ACTA CLINICA BELGICA, 2023, 78 (01) : 78 - 86
  • [6] Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults
    Thompson, Allison
    Lamberth, Erik
    Severs, Joseph
    Scully, Ingrid
    Tarabar, Sanela
    Ginis, John
    Jansen, Kathrin U.
    Gruber, William C.
    Scott, Daniel A.
    Watson, Wendy
    VACCINE, 2019, 37 (42) : 6201 - 6207
  • [7] Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults
    Rey-Ares, Lucila
    Averin, Ahuva
    Mac Mullen, Mercedes
    Hariharan, Dhwani
    Atwood, Mark
    Carballo, Carolina
    Huang, Liping
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (06) : 1235 - 1251
  • [8] Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infants
    Rozenbaum, Mark H.
    Huang, Liping
    Perdrizet, Johnna
    Cane, Alejandro
    Arguedas, Adriano
    Hayford, Kyla
    Tort, Maria J.
    Chapman, Ruth
    Dillon-Murphy, Desmond
    Snow, Vincenza
    Chilson, Erica
    Farkouh, Raymond A.
    VACCINE, 2024, 42 (03) : 573 - 582
  • [9] Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
    Gourzoulidis, George
    Barmpouni, Myrto
    Kossyvaki, Vasiliki
    Vietri, Jeffrey
    Tzanetakos, Charalampos
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [10] COST-EFFECTIVENESS OF THE 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE VS 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE FOR A./ULTS IN ARGENTINA
    Mac Mullen, M.
    Carballo, C.
    Seyahian, E.
    VALUE IN HEALTH, 2022, 25 (12) : S132 - S132
12345